Trivorin

Trivorin is a drug against the hepatitis C virus, which is produced in Israel by Teva Pharmaceuticals. It belongs to a group of antiviral drugs called nucleosides. Trivorin is prescribed for the treatment of chronic hepatitis C virus infection in adults and children over 12 years of age, but it is also used as an adjunctive treatment to interferon-alpha in patients who are resistant to interferon-alpha treatment.

The medicine is contraindicated in chronic heart failure IIB/III degree, myocardial infarction, renal failure, anemia, severe liver dysfunction, autoimmune and autoimmune hepatitis. Taking Trivorin is also contraindicated in pregnant and lactating women who suffer from severe depression with suicidal intent and who have hypersensitivity to the drug. Treatment should be carried out under the strict supervision of a doctor or hepatitis C specialist.

Possible side effects include hemolytic anemia, abnormal